12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
周四盘后交易时段，12只医疗保健股走势
Gainers
获胜者
- Regulus Therapeutics (NASDAQ:RGLS) stock increased by 12.4% to $1.45 during Thursday's after-market session. The company's market cap stands at $28.2 million.
- SeqLL (NASDAQ:SQL) shares moved upwards by 10.34% to $15.79. The company's market cap stands at $6.0 million.
- bioAffinity Technologies (NASDAQ:BIAF) shares moved upwards by 9.43% to $1.16. The market value of their outstanding shares is at $10.1 million.
- Enveric Biosciences (NASDAQ:ENVB) shares increased by 9.05% to $2.65. The market value of their outstanding shares is at $5.7 million.
- Blue Water Biotech (NASDAQ:BWV) shares rose 8.67% to $0.61. Trading volume for this security closed at 129.4K, accounting for 130.5% of its average full-day volume over the last 100 days. The company's market cap stands at $9.7 million.
- China Pharma Holding (AMEX:CPHI) stock rose 7.01% to $0.14. At the close, China Pharma Holding's trading volume reached 65.8K shares. This is 7.2% of its average volume over the last 100 days. The company's market cap stands at $1.6 million.
- 雷古勒斯疗法 纳斯达克股票代码：RGLS）股价在周四的盘后交易时段上涨了12.4％，至1.45美元。该公司的市值为2,820万美元。
- SeqLL 纳斯达克股票代码：SQL）股价上涨10.34％，至15.79美元。该公司的市值为600万美元。
- 生物亲和性技术 纳斯达克股票代码：BIAF）股价上涨9.43％，至1.16美元。他们流通股的市值为1,010万美元。
- 恩维里克生物科学 纳斯达克股票代码：ENVB）股价上涨9.05％，至2.65美元。他们流通股的市值为570万美元。
- 蓝水生物科技 纳斯达克股票代码：BWV）股价上涨8.67％，至0.61美元。该证券的交易量收于12.94万，占其过去100天平均全天交易量的130.5％。该公司的市值为970万美元。
- 中国医药控股 美国证券交易所股票代码：CPHI）股价上涨7.01％，至0.14美元。收盘时，中国医药控股的交易量达到6.58万股。这是其过去100天平均交易量的7.2％。该公司的市值为160万美元。
Losers
失败者
- Baudax Bio (NASDAQ:BXRX) shares decreased by 10.1% to $0.31 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.
- Surrozen (NASDAQ:SRZN) stock declined by 6.49% to $0.43. The market value of their outstanding shares is at $13.0 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 6.45% to $0.65. Today's trading volume for this security ended up closing at 583.3K shares, which is 103.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 million.
- IGC Pharma (AMEX:IGC) stock fell 5.33% to $0.37. The market value of their outstanding shares is at $19.9 million.
- Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 4.63% to $2.89. The market value of their outstanding shares is at $540.3 million.
- TRACON Pharma (NASDAQ:TCON) stock decreased by 4.57% to $0.21. The market value of their outstanding shares is at $6.4 million. See Also:
- Baudax Bio 纳斯达克股票代码：BXRX）股价在周四的盘后交易时段下跌10.1％，至0.31美元。他们流通股的市值为280万美元。
- Surroze 纳斯达克股票代码：SRZN）股价下跌6.49％，至0.43美元。他们流通股的市值为1,300万美元。
- TransCode 治疗学 纳斯达克股票代码：RNAZ）股价下跌6.45％，至0.65美元。该证券今天的交易量最终收于58.33万股，占其过去100天平均交易量的103.7％。他们流通股的市值为130万美元。
- IGC 制药 美国证券交易所股票代码：IGC）股价下跌5.33％，至0.37美元。他们流通股的市值为1,990万美元。
- Taysha 基因疗法 纳斯达克股票代码：TSHA）股价下跌4.63％，至2.89美元。他们流通股的市值为5.403亿美元。
- 特拉康制药 纳斯达克股票代码：TCON）股价下跌4.57％，至0.21美元。他们流通股的市值为640万美元。 另请参阅：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。